XML 47 R37.htm IDEA: XBRL DOCUMENT v3.19.2
Major Customers, Partnerships and Strategic Alliances - Revenues Recognized under Agreement (Detail) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Research and Development Arrangement, Contract to Perform for Others [Line Items]        
Revenues $ 17,548 $ 21,416 $ 25,619 $ 34,053
Kite Pharma Inc        
Research and Development Arrangement, Contract to Perform for Others [Line Items]        
Revenues 9,060 7,515 17,372 7,515
Kite Pharma Inc | Collaboration Agreements        
Research and Development Arrangement, Contract to Perform for Others [Line Items]        
Revenues 6,227 5,953 12,386 5,953
Kite Pharma Inc | Research Services        
Research and Development Arrangement, Contract to Perform for Others [Line Items]        
Revenues 2,833 1,562 4,986 1,562
Pfizer SB-525 | Collaboration Agreements        
Research and Development Arrangement, Contract to Perform for Others [Line Items]        
Revenues 4,635 8,183 1,595 15,841
Pfizer        
Research and Development Arrangement, Contract to Perform for Others [Line Items]        
Revenues     25,600  
Pfizer | Collaboration Agreements        
Research and Development Arrangement, Contract to Perform for Others [Line Items]        
Revenues 455 617 1,070 1,076
Bioverativ Inc        
Research and Development Arrangement, Contract to Perform for Others [Line Items]        
Revenues 3,059 4,516 5,009 8,898
Bioverativ Inc | Collaboration Agreements        
Research and Development Arrangement, Contract to Perform for Others [Line Items]        
Revenues 901 1,184 1,654 2,338
Bioverativ Inc | Research Services        
Research and Development Arrangement, Contract to Perform for Others [Line Items]        
Revenues $ 2,158 $ 3,332 $ 3,355 $ 6,560